Allergan plc (AGN) Investor Lawsuit alleges False and Misleading Statements

An investor in shares of Allergan plc (NYSE:AGN) filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Allergan plc (NYSE:AGN in connection with certain allegedly false and misleading statements.

Investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) have certain options and for certain investors are short and strict deadlines running. Deadline: August 29, 2017. Allergan plc (NYSE:AGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The plaintiff alleges on behalf of investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) common shares between February 25, 2014 through April 21, 2014, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between February 25, 2014 through April 21, 2014, certain Defendants traded on material non-public information regarding the proposed acquisition, and as a result, investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan, Inc between February 25, 2014 through April 21, 2014 did so at prices that did not reflect the material nonpublic information known to Defendants. In this action, Plaintiff seeks an award of damages, and prejudgment interest, to Plaintiff and investors who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) common shares between February 25, 2014 through April 21, 2014.

Those who sold the call options, purchased the put options and/or sold equity forward contracts of Allergan plc (NYSE:AGN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com